학술논문

Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma - Cancer and leukemia group B 509901
Document Type
Journal
Source
JOURNAL OF IMMUNOTHERAPY; JAN-FEB 2006, 29 1, p95-p101, 7p.
Subject
Language
English
ISSN
15249557